Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.
Intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime was surveyed for 3 years in a hematology-oncology unit. Of 416 patients, 66 (15.9%) were colonized, each with a different strain. The incidence of intestinal carriage was not correlated with cefotaxime consumption in the ward but was strongly associated with individual exposure to cefotaxime.
D000380:Agranulocytosis / Q000150:complications*; D002439:Cefotaxime / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects / Q000254:growth & development* / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D006757:Hospital Units; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D009503:Neutropenia / Q000150:complications*; D018805:Sepsis / Q000382:microbiology
D002439:Cefotaxime